WHWK · Whitehawk Therapeutics

Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in August 2021. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey.

2 Headquarters Plaza, Morristown, NJ, 07960, United States
Biotechnology
Healthcare

Market Cap

181.2M

52 Wk Range

$1.97 - $5.50

Previous Close

$3.07

Open

$3.07

Volume

212,183

Day Range

$2.91 - $3.10

Enterprise Value

21.74M

Cash

169.7M

Avg Qtr Burn

-19.67M

Insider Ownership

12.20%

Institutional Own.

80.72%

Qtr Updated

Sep 30th 2026